Homo sapiens Protein: CDKN3 | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||
InnateDB Protein | IDBP-369294.5 | ||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||
Gene Symbol | CDKN3 | ||||||||||||||||||
Protein Name | cyclin-dependent kinase inhibitor 3 | ||||||||||||||||||
Synonyms | CDI1; CIP2; KAP; KAP1; | ||||||||||||||||||
Species | Homo sapiens | ||||||||||||||||||
Ensembl Protein | ENSP00000415333 | ||||||||||||||||||
InnateDB Gene | IDBG-6996 (CDKN3) | ||||||||||||||||||
Protein Structure | |||||||||||||||||||
UniProt Annotation | |||||||||||||||||||
Function | May play a role in cell cycle regulation. Dual specificity phosphatase active toward substrates containing either phosphotyrosine or phosphoserine residues. Dephosphorylates CDK2 at 'Thr-160' in a cyclin-dependent manner. {ECO:0000269PubMed:7569954, ECO:0000269PubMed:8127873, ECO:0000269PubMed:8242750}. | ||||||||||||||||||
Subcellular Localization | Cytoplasm, perinuclear region {ECO:0000269PubMed:10669749}. | ||||||||||||||||||
Disease Associations | Hepatocellular carcinoma (HCC) [MIM:114550]: A primary malignant neoplasm of epithelial liver cells. The major risk factors for HCC are chronic hepatitis B virus (HBV) infection, chronic hepatitis C virus (HCV) infection, prolonged dietary aflatoxin exposure, alcoholic cirrhosis, and cirrhosis due to other causes. {ECO:0000269PubMed:10987270}. Note=The gene represented in this entry may be involved in disease pathogenesis. | ||||||||||||||||||
Tissue Specificity | |||||||||||||||||||
Comments | |||||||||||||||||||
Interactions | |||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 12 experimentally validated interaction(s) in this database.
|
||||||||||||||||||
Gene Ontology | |||||||||||||||||||
Molecular Function |
|
||||||||||||||||||
Biological Process |
|
||||||||||||||||||
Cellular Component |
|
||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||
PDB ID | |||||||||||||||||||
InterPro |
IPR000242
Protein-tyrosine phosphatase, receptor/non-receptor type IPR000340 Dual specificity phosphatase, catalytic domain IPR000387 Protein-tyrosine/Dual specificity phosphatase IPR003595 Protein-tyrosine phosphatase, catalytic IPR008425 Cyclin-dependent kinase inhibitor 3 IPR022778 CDKN3 domain IPR029021 Protein-tyrosine phosphatase-like |
||||||||||||||||||
PFAM |
PF00102
PF00782 PF05706 |
||||||||||||||||||
PRINTS |
PR00700
|
||||||||||||||||||
PIRSF |
PIRSF037322
|
||||||||||||||||||
SMART |
SM00194
SM00404 |
||||||||||||||||||
TIGRFAMs | |||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||
Modification | |||||||||||||||||||
Cross-References | |||||||||||||||||||
SwissProt | Q16667 | ||||||||||||||||||
PhosphoSite | PhosphoSite-Q16667 | ||||||||||||||||||
TrEMBL | |||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||
Entrez Gene | 1033 | ||||||||||||||||||
UniGene | Hs.733107 | ||||||||||||||||||
RefSeq | NP_001124323 | ||||||||||||||||||
HUGO | HGNC:1791 | ||||||||||||||||||
OMIM | 123832 | ||||||||||||||||||
CCDS | CCDS45109 | ||||||||||||||||||
HPRD | 00450 | ||||||||||||||||||
IMGT | |||||||||||||||||||
EMBL | AF213033 AF213036 AF213038 AF213039 AF213041 AF213042 AF213046 AF213047 AF213049 AF213053 AY194117 AY257474 BC064965 BT019451 CH471061 CR407666 EF560750 L25876 L27711 U02681 | ||||||||||||||||||
GenPept | AAA60222 AAA66496 AAC04932 AAH64965 AAK06365 AAK06368 AAK06370 AAK06371 AAK06373 AAK06374 AAK06377 AAK06378 AAK06380 AAK06384 AAN86348 AAP13062 AAV38258 ABQ59060 CAG28594 EAW80632 EAW80634 | ||||||||||||||||||